Cronos Group Inc.
General ticker "CRON" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $957.9M (TTM average)
Cronos Group Inc. follows the US Stock Market performance with the rate: 47.4%.
Estimated limits based on current volatility of 2.0%: low 2.59$, high 2.69$
Factors to consider:
- Total employees count: 610 (+32.9%) as of 2025
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Intellectual property risks, Reputation and brand risks
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.94$, 3.75$]
- 2026-12-31 to 2027-12-31 estimated range: [1.81$, 3.54$]
Financial Metrics affecting the CRON estimates:
- Positive: with PPE of -189.1 at the end of fiscal year the price was very low
- Positive: -5.39 < Operating profit margin, % of -1.49
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of -0.78
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Shareholder equity ratio, % of 91.38 > 64.29
Short-term CRON quotes
Long-term CRON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $87.24MM | $117.61MM | $193.36MM |
| Operating Expenses | $172.04MM | $194.14MM | $196.29MM |
| Operating Income | $-84.80MM | $-76.53MM | $-2.93MM |
| Non-Operating Income | $11.13MM | $113.11MM | $-14.19MM |
| R&D Expense | $5.84MM | $4.23MM | $4.45MM |
| Income(Loss) | $-73.67MM | $36.59MM | $-17.12MM |
| Taxes | $-3.23MM | $-3.44MM | $-7.67MM |
| Net Income(Loss)* | $-73.96MM | $41.08MM | $-18.89MM |
| Stockholders Equity | $1,099.57MM | $1,064.06MM | $1,093.90MM |
| Inventory | $30.50MM | $33.15MM | $46.75MM |
| Assets | $1,140.27MM | $1,166.31MM | $1,197.14MM |
| Operating Cash Flow | $-42.84MM | $18.84MM | $25.87MM |
| Capital expenditure | $3.42MM | $13.15MM | $26.17MM |
| Investing Cash Flow | $-59.50MM | $175.15MM | $-76.56MM |
| Financing Cash Flow | $-1.03MM | $-1.23MM | $-19.91MM |
| Earnings Per Share** | $-0.18 | $0.11 | $-0.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.